ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: However, GMB-475 showed significant effects of growth inhibition and promoted apoptosis in CML cell lines carrying BCR::ABL1 mutants only at high drug concentrations and performed a poor treatment effect on the CML mouse model.